RECRUITING

Characterization of Gastric Evoked Potentials

Talk to us

Conditions

Healthy

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This is an exploratory study that will determine and standardize how best to record gastric evoked potentials (GEPs) elicited by a non-invasive method of brain stimulation (Transcranial Magnetic Stimulation, TMS), by optimizing the TMS parameters and cortical sites necessary to evoke GEPs.

Official Title

Characterization of Gastric Evoked Potentials

Quick Facts

Study Start:2023-07-17
Study Completion:2026-07
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT05924009

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:21 Years to 60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:Yes
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. Age 18 years or older
  2. Willing and able to provide informed consent
  3. Able to understand and follow study procedures
  4. Stable medical condition
  1. * psychosis or altered cognitive status
  2. * history of head injury, metal in the skull, stroke, or a history of seizures, loss of consciousness or syncope
  3. * implantable devices, such as a pacemaker or nerve stimulator
  4. * current use of antiepileptic medications or current use of the following medications or substances which are known to lower the seizure threshold: Clozapine (Clozaril), Chlorpromazine (Thorazine), amphetamines or methamphetamine, Ecstasy, Ketamine, Angel Dust/PCP, cocaine, or 3 or more alcoholic drinks per day
  5. * pregnancy
  6. * BMI \> 30
  7. * history of bariatric surgery such as sleeve gastrectomy or Roux-en-Y gastric bypass
  8. * diabetes
  9. * suffering from a neurodegenerative disorder.

Contacts and Locations

Study Contact

Paul HM Kullmann, PhD
CONTACT
412-647-1533
phmk@pitt.edu
David J Levinthal, MD PhD
CONTACT
412-303-0525
levinthald@upmc.edu

Principal Investigator

David J Levinthal, MD PhD
PRINCIPAL_INVESTIGATOR
University of Pittsburgh

Study Locations (Sites)

University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15232
United States

Collaborators and Investigators

Sponsor: University of Pittsburgh

  • David J Levinthal, MD PhD, PRINCIPAL_INVESTIGATOR, University of Pittsburgh

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2023-07-17
Study Completion Date2026-07

Study Record Updates

Study Start Date2023-07-17
Study Completion Date2026-07

Terms related to this study

Additional Relevant MeSH Terms

  • Healthy